q3 non-gaap earnings per share $3.71.
q3 sales rose 15.4 percent to $747 million.
bio rad laboratories - now anticipates 2021 non-gaap currency-neutral revenue growth between 12 to 13 percent.
sees 2021 estimated non-gaap operating margin of about 19.5 percent.
qtrly gaap income per share $129.96.
